Clinical Trials Sponsored by FLUIDDA nv

Total 340 results

Janssen-Cilag International NV

Completed

An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation (REPLACE)

Chronic Hepatitis C Virus (HCV) Infection

France, United Kingdom, Spain, Germany, Belgium, Austria
Janssen-Cilag International NV

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants

Healthy

Netherlands
Janssen-Cilag International NV

Completed

A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting (HOSPIPalm)

Schizophrenia

Germany, Bulgaria, Israel, Russian Federation, Greece, Belgium, Denmark, Kazakhstan
Janssen-Cilag International NV

Completed

Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics (PROSIPAL)

Schizophrenia

France, Ukraine, United Kingdom, Germany, Taiwan, Spain, Poland, Bulgaria, Romania, Russian Federation, South Africa, Greece, Israel, Korea, Republic of, Belgium, Estonia, Turkey, Czech Republic, Austria, Hungary, Lithuania, Slovakia and more
Janssen-Cilag International NV

Completed

An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma

Multiple Myeloma

France, Belgium, Germany, Spain, Portugal, Greece, Austria, Luxembourg
Janssen-Cilag International NV

Completed

A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder

Attention Deficit/ Hyperactivity Disorder

France, Belgium, Germany, Spain, Switzerland, Denmark, Finland, Netherlands, Norway, Sweden, United Kingdom
Janssen-Cilag International NV

Completed

Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee

Pain | Osteoarthritis, Knee | Osteoarthritis, Hip

United Kingdom, Romania, Slovakia, Czech Republic
Janssen-Cilag International NV

Completed

Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

France, Germany, Spain, Switzerland, Netherlands, Portugal, Norway
Janssen-Cilag International NV

Terminated

Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma

Multiple Myeloma

Poland, Turkey, Russian Federation, Hungary, Lithuania, Croatia, Germany
Janssen-Cilag International NV

Completed

An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia (PERTAIN)

Schizophrenia

Poland, Israel, Romania, Germany, Lithuania, Croatia, France
Janssen-Cilag International NV

Completed

Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma

Multiple Myeloma
Janssen-Cilag International NV

Completed

Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics (PILAR)

Schizophrenia

Ukraine, Canada, Sweden, Czech Republic, Denmark, Thailand, Kazakhstan
Galapagos NV
PRA Health Sciences

Completed

Bioavailability Study With GLPG1972

Osteoarthritis

Netherlands
University Hospital, Antwerp
YUN NV

Recruiting

Study of the Skin Microbiome and the Potential of a Topical Probiotic Cream for Atopic Dermatitis

Atopic Dermatitis

Belgium
Oncurious NV
Beat Childhood Cancer

Completed

A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma

Relapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)

United States
Ectosense NV
Ziekenhuis Oost-Limburg

Unknown

Prospective Validation Study of a Novel Type IV Home Sleep Apnea Test

Sleep Apnea

Belgium
Universiteit Antwerpen
Stöpler Belgium nv

Unknown

Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation.

Total Hip Arthroplasty

Belgium
Origo Biopharma

Completed

First in Human Study of ORG-129 in Healthy Volunteers

Healthy Volunteers

Spain
Ectosense NV
Ziekenhuis Oost-Limburg

Unknown

Extensive Prospective Validation Study of the NightOwl Home Sleep Apnea Test

Sleep Apnea

Belgium
Therabel Pharma SA/NV
ECSOR

Unknown

Prevention of Antibiotic-Associated Diarrhoea With Prolardii (PAADI)

Antibiotic-associated Diarrhea

Belgium
Agomab Spain S.L.

Recruiting

STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

Fibrostenotic Crohn's Disease

United States, Italy, Poland, Spain, Denmark, Austria, Canada, Germany
Cosmo Technologies Ltd

Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Advanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10

United States
Agomab Spain S.L.

Completed

Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

Healthy Volunteers

Belgium
Agomab Spain S.L.

Completed

Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants

Healthy Volunteers

Belgium
Cosmo Technologies Ltd

Completed

Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea

Infectious Diarrhoea
University Hospital, Ghent
Pilipili NV; Imec

Terminated

EEG@HOME (Phase 3b of the Project, Interviews)

Epilepsy

Belgium
University Hospital, Ghent
Pilipili NV; Imec

Completed

EEG@HOME (Phase 2 of the Project, Measurements in Healthy Volunteers)

Epilepsy

Belgium
University Hospital, Ghent
Pilipili NV; Imec

Completed

EEG@HOME (Phase 1 of the Project)

Epilepsy

Belgium
Agomab Spain S.L.

Recruiting

Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF

IPF

United Kingdom
Leiden University Medical Center
Galapagos NV

Recruiting

JAK Inhibition in Ulcerative Colitis

Colitis, Ulcerative

Netherlands
Janssen-Cilag International NV
Grünenthal GmbH

Completed

A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo

Hallux Valgus

Taiwan
Leiden University Medical Center
Galapagos NV

Not yet recruiting

Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis (JAKAR)

Rheumatoid Arthritis

Netherlands
University Hospital, Grenoble
Chiesi SA/NV

Recruiting

Tacrolimus Pharmacokinetic Subpopulations (TIPS)

Kidney Transplant Failure and Rejection | Immunosuppression-related Infectious Disease

France
Indigo Diabetes NV
University Hospital, Antwerp

Completed

The GLOW Study - The YANG System

Diabetes Mellitus | Glucose

Belgium
Cosmo Technologies Ltd

Completed

Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D

Diarrhea-predominant Irritable Bowel Syndrome

Belgium, Germany, Italy, Spain
Hoffmann-La Roche
nv Roche sa

Completed

An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice

Rheumatoid Arthritis

Belgium, Luxembourg
University Hospital, Ghent
Pilipili NV; Imec

Completed

EEG@HOME (Phase 3a of the Project, Comparison of EEG-recordings)

Epilepsy

Belgium
YUN NV
Allergisa Pesquisa Dermato-Cosmetica LTDA

Completed

Skin Acceptance and Efficacy Assessment of a Topical Product in Acne Treatment When Compared to a Placebo.

Acne Vulgaris

Brazil
Lymphoma Study Association
Janssen-Cilag International NV

Completed

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma

France, Belgium
University Hospital, Ghent
Bekaert textiles NV Waregem

Completed

House Dust Mite Allergen Reduction in Bedding: Purotex Impregnated Covers of Bekaert Textiles (Purotex covers)

Allergic Rhinitis

Belgium
Medical Device Works NV SA
Celerion; Cromsource

Unknown

Liver-PILP First-in-Man (PILP FiM)

Liver Metastases

Belgium
Galapagos NV
Institut de Recherches Internationales Servier

Completed

A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis (Roccella)

Osteoarthritis

United States
Institute of Tropical Medicine, Belgium
Novosanis NV

Completed

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (Colli-Pee)

Sexually Transmitted Diseases, Bacterial

Belgium
Galapagos NV
Pharmaceutical Research Associates; SGS S.A.

Completed

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Female Subjects

Healthy

Belgium
Lymphoma Study Association
Janssen-Cilag International NV

Terminated

A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma

Follicular Lymphoma

France, Belgium
NHS Greater Glasgow and Clyde
Galapagos NV

Recruiting

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis (TEMPO)

Rheumatoid Arthritis | Pain, Chronic | Autoimmune | Inflammatory Disease | Sickness Behavior

United Kingdom
Apitope International NV
Quintiles, Inc.; European Commission

Completed

ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy

Graves Disease

United Kingdom
University Hospital, Antwerp
Universiteit Antwerpen; Eurogenerics NV

Completed

Effectiveness of Influenza Vaccination Among General Practitioners

Influenza
European Institute of Oncology
Janssen-Cilag International NV

Active, not recruiting

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Breast Cancer

Italy
Cosmo Artificial Intelligence-AI Ltd

Completed

Polyp REcognition Assisted by a Device Interactive Characterization Tool - The PREDICT Study (PREDICT)

Artificial Intelligence

Italy

Clinical Trials Sponsored by FLUIDDA nv

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations